An experimental therapy that tweaks cancer patients’ immune cells to recognize an often-deadly form of leukemia has shrunk tumours and sent the cancer into remission in adults, according U.S. researchers. Scientists said the finding, which was based on a study of five adults, had “life-saving potential.” The study was published in the journal Science Translational Medicine. Read more here.
Study mentioned: Brentjens RJ, et al. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia. Sci Transl Med. 2013 Mar 20;5(177):177ra38. PMID: 23515080
No comments:
Post a Comment